Haldol conversion to decanoate

An assessment for an underlying cause of behavior is needed before prescribing antipsychotic medication for symptoms of dementia . [32] Antipsychotics in old age dementia showed a modest benefit compared to placebo in managing aggression or psychosis, but this is combined with a fairly large increase in serious adverse events. Thus, antipsychotics should not be used routinely to treat dementia with aggression or psychosis, but may be an option in a few cases where there is severe distress or risk of physical harm to others. [33] Psychosocial interventions may reduce the need for antipsychotics. [34]

The influence of renal impairment on the pharmacokinetics of haloperidol has not been evaluated. About one-third of a haloperidol dose is excreted in urine, mostly as metabolites. Less than 3% of administered haloperidol is eliminated unchanged in the urine. Haloperidol metabolites are not considered to make a significant contribution to its activity, although for the reduced metabolite of haloperidol, back-conversion to haloperidol cannot be fully ruled out. Even though impairment of renal function is not expected to affect haloperidol elimination to a clinically relevant extent, caution is advised in patients with renal impairment, and especially those with severe impairment, due to the long half-life of haloperidol and its reduced metabolite, and the possibility of accumulation (see section ).

Haldol conversion to decanoate

haldol conversion to decanoate

Media:

haldol conversion to decanoatehaldol conversion to decanoatehaldol conversion to decanoatehaldol conversion to decanoatehaldol conversion to decanoate